Diet-induced obese mice are leptin insufficient after weight reduction.
Behavioral therapies aimed at reducing excess body fat result in limited fat loss after dieting. To understand the causes for maintenance of adiposity, high-fat (HF) diet-induced obese (DIO) mice were switched to a low-fat chow diet, and the effects of chow on histological and molecular alterations of adipose tissue and metabolic parameters were examined. DIO mice reduced and stabilized their body weights after being switched to chow (HF-chow), but retained a greater amount of adiposity than chow-fed mice. Reduction in adipocyte volume, not number, caused a decrease in fat mass. HF-chow mice showed normalized circulating insulin and leptin levels, improved glucose tolerance, and reduced inflammatory status in white adipose tissue (WAT). Circulating leptin levels corrected for fat mass were lower in HF-chow mice. Leptin administration was used to test whether reduced leptin level of HF-chow mice inhibited further fat loss. Leptin treatment led to an additional reduction in adiposity. Finally, HF-HF mice had lower mRNA levels of beta(3) adrenergic receptor (beta(3)-AR) in epididymal WAT (EWAT) compared to chow-fed mice, and diet change led to an increase in the WAT beta(3)-AR mRNA levels that were similar to the levels of chow-fed mice, suggesting an elevation in sympathetic activation of WAT during diet switch relative to HF-HF mice leading to the reduced leptin level and proinflammatory cytokine content. In summary, HF-chow mice were resistant to further fat loss due to leptin insufficiency. Diet alteration from HF to low fat improved metabolic state of DIO mice, although their adiposity was defended at a higher level.
Shi
Haifei
H
Obesity Research Center, Department of Psychiatry, University of Cincinnati, Cincinnati, Ohio, USA.
Akunuru
Shailaja
S
Bierman
John C
JC
Hodge
Karen M
KM
Mitchell
M Chrissy
MC
Foster
Michelle T
MT
Seeley
Randy J
RJ
Reizes
Ofer
O
D002001:Adipose Tissue, Brown / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D052436:Adipose Tissue, White / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D050154:Adiposity; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D048429:Cell Size; D018752:Diet, Fat-Restricted; D004041:Dietary Fats / Q000008:administration & dosage; D004195:Disease Models, Animal; D004435:Eating; D005234:Fatty Liver / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D005247:Feeding Behavior; D007249:Inflammation / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D007328:Insulin / Q000097:blood; D020738:Leptin / Q000097:blood / Q000172:deficiency*; D008264:Macrophages / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009765:Obesity / Q000178:diet therapy* / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D012333:RNA, Messenger / Q000378:metabolism; D022702:Receptors, Adrenergic, beta-3 / Q000235:genetics; D013997:Time Factors; D015431:Weight Loss
D001786:Blood Glucose; D004041:Dietary Fats; D007328:Insulin; D020738:Leptin; D012333:RNA, Messenger; D022702:Receptors, Adrenergic, beta-3